Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study

September 21, 2023 updated by: David García Azorín, Hospital Clínico Universitario de Valladolid
Observational analytic study with prospective cohort design that aim to describe the presence of typical features of migraine in a cohort of nummular headache patients. The aim of the study is to analyze family history, epidemiology, clinical description, presence of prodromes, postdromes and response to treatment.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Background:

Nummular headache (NH) is a primary headache included in the International Classification of Headache Disorders (ICHD) characterized by a well delimited superficial pain, with sharp border, felt in a rounded or elliptical 1-6 centimeters area. Pain might be continuous or intermittent. The key feature of nummular headache is the fixed superficial topography.

The real nature of this condition is still a matter of controversial. Some authors defend it as a specific condition with a particular pathophysiology; whereas others consider that it might be a localized form of migraine with a shared phenotype and pathophysiology.

Among the arguments that defend its existence as a differentiated entity we include: the older age of onset, the fixed and localized pain without pain in other territories, presence of trophic changes, the localized abnormality in pressure pain threshold determination, the description of secondary cases, the description of posttraumatic cases or the specific therapeutic response.

On the other hand, in some cases hypersensitivity to stimuli has been described, other typical migrainous symptoms such as nausea or vomiting might be present, and some patients respond to triptans or other migraine prophylactics.

Information is scarce about the presence of prodromes, postdromes or family history of migraine. Moreover, little is known about NH pathophysiology, some studies suggest an impairment in superficial sensory fibers because a localized alteration of pressure-pain threshold. No imaging or laboratory studies have been done so far.

This is a proof of concept study. The aim is to analyze if patients with a definite NH diagnosis according to ICHD present any shared epidemiological, clinical or therapeutical features with migraine.

Hypothesis:

Nummular headache might be a specific condition or it might share migraine biologic features. The detailed description of it might help to clarify whether if NH is a single entity or a focal presentation form of migraine.

Objective:

To describe the presence of typical features of migraine in a cohort of NH patients, including family history, epidemiology, clinical description, presence of prodromes or postdromes and response to treatment.

Methods:

The study has an observational analytic design following the Strengthening the Reporting of Observational in Epidemiology (STROBE) guidelines. Patients with definite nummular headache diagnosis according to The International Classification of Headache Disorders1 will be invited to participate. The study will be conducted in the Headache Unit of Hospital Clinico Universitario de Valladolid, a third level hospital sited in Valladolid, with a reference population of 280.000 people.

Intervention:

The study will be divided into different sections:

  1. Family history of headache and in particular, migraine.
  2. Epidemiology of NH patients.
  3. Clinical phenotype and pattern of the headache.
  4. Associated symptoms, presence of prodromes and postdromes.
  5. Physical examination.
  6. Prior treatment use, tolerability and response.

Selection of participants:

Recruitment will be recruited by a non-probabilistic sampling method by convenience and by formal invitation if they are included in the clinical registry of the Headache Unit of the Hospital Clinico Universitario de Valladolid.

In the first visit participants will be examined by a neurologist with experience in headache disorders and NH diagnosis will be reviewed. Patients will be invited to participate into the study and they will provide and sign informed consent form. They will be instructed and trained to complete the prospective headache diary during 14 days. A follow up visit will be done within 15 to 30 days to review the data and analyze possible sources of bias.

Study Type

Observational

Enrollment (Actual)

19

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valladolid, Spain, 47003
        • Hospital Clinico Universitario Valladolid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with definite diagnosis of nummular headache that visit the headache outpatient clinic of Valladolid University Hospital.

Description

Inclusion Criteria:

  1. Diagnosis of Nummular Headache (NH) according to the International Classification of Headache Disorders, 3rd version (ICHD-3).
  2. More than 3 months of NH evolution.
  3. No better accounted for by another ICHD-3 diagnosis.
  4. Older than 18 years.
  5. Capable of prospectively register headache characteristics in a diary.
  6. Ability to provide informed consent form.

Exclusion Criteria:

  1. Other primary or secondary headache, except for infrequent tension-type headache or medication overuse headache.
  2. Major psychiatric disorders.
  3. Alcoholism or drug use.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family history of migraine
Time Frame: Through study completion, an average of 1 month
To assess family history of migraine headache in nummular patients. We will build family tree up to 3 generations and we will ask patients to complete it by questioning their relatives.
Through study completion, an average of 1 month
Epidemiological pattern
Time Frame: Through study completion, an average of 1 month
To determine age of onset, age when they were diagnosed, temporal pattern and frequency of headache.
Through study completion, an average of 1 month
Clinical phenotype
Time Frame: Through study completion, an average of 1 month
To assess the clinical characteristics of nummular headache, analyzing the presence of typical features of migraine. Patients will complete a prospective headache diary for 15 days.
Through study completion, an average of 1 month
Presence of associated symptoms
Time Frame: Through study completion, an average of 1 month
To assess the presence of symptoms such as nausea, vomiting, dizziness during the headache episodes.
Through study completion, an average of 1 month
Presence of prodromes
Time Frame: Through study completion, an average of 1 month
To assess the presence of typical migraine prodromes before the headache episodes.
Through study completion, an average of 1 month
Presence of postdromes
Time Frame: Through study completion, an average of 1 month
To assess the presence of typical migraine postdromes after the headache episode.
Through study completion, an average of 1 month
Presence of sensory disturbances
Time Frame: Through study completion, an average of 1 month
To evaluate the presence of sensory changes such as hypoesthesia, hyperalgesia or allodinia upon examination.
Through study completion, an average of 1 month
Response to acute treatment
Time Frame: Through study completion, an average of 1 month
To describe response to prior acute medications.
Through study completion, an average of 1 month
Response to prophylactic treatment
Time Frame: Through study completion, an average of 1 month
To assess response to prior prophylactic treatments.
Through study completion, an average of 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2020

Primary Completion (Actual)

March 25, 2023

Study Completion (Actual)

April 25, 2023

Study Registration Dates

First Submitted

March 5, 2020

First Submitted That Met QC Criteria

March 6, 2020

First Posted (Actual)

March 9, 2020

Study Record Updates

Last Update Posted (Actual)

September 22, 2023

Last Update Submitted That Met QC Criteria

September 21, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

To be decided if anonymous data-sheets are available for other researchers upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Migraine

Clinical Trials on Patient diary

Subscribe